InMode announced receipt of an unsolicited acquisition proposal, confirming that a buyer—identity undisclosed—has expressed interest in acquiring the Israeli energy-device company. InMode manufactures RF microneedling, fractional RF, and other modalities under brands including Morpheus8 and EvoluTION, and has built significant market share in the U.S. aesthetic and surgical markets.
The proposal underscores ongoing appetite among PE firms and strategic buyers (device roll-ups, larger medtech companies) to consolidate aesthetic-device platforms. InMode's profitability, recurring revenue model (consumable tips and handpieces), and installed base make it an attractive target. The company's board is evaluating the proposal; no deal is certain.